Atara Biotherapeutics, Price Chart
Atara Biotherapeutics, Volume Chart
Atara Biotherapeutics, Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
-0.01(-0.10%)
| Open | $5.00 |
|---|---|
| Close | $5.00 |
| Low | $4.87 |
| Low Change | -0.13 (-2.60%) |
| High | $5.26 |
| High Change | +0.26 (+5.20%) |
| Range | $0.39 |
| Volume | 41.807K |
| Dollar Volume | $208.83K |
Premarket
-0.07(-1.39%)
| Open | $5.02 |
|---|---|
| Close | $4.95 |
| Low | $4.95 |
| Low Change | -0.07 (-1.39%) |
| High | $5.02 |
| High Change | +0.00 (+0.00%) |
| Range | $0.07 |
| Volume | 600 |
| Dollar Volume | $2.97K |
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.33(+6.79%)
| Open | $4.86 |
|---|---|
| Close | $5.19 |
| Low | $4.78 |
| Low Change | -0.09 (-1.75%) |
| High | $5.25 |
| High Change | +0.39 (+8.02%) |
| Range | $0.48 |
| Volume | 72.115K |
| Dollar Volume | $374.28K |
Premarket Yesterday
+0.00(+0.00%)
| Open | $5.00 |
|---|---|
| Close | $5.00 |
| Low | $5.00 |
| Low Change | 0.00 (0.00%) |
| High | $5.00 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 100 |
| Dollar Volume | $499.99 |
Atara Biotherapeutics, Moving Averages
| 5 Day Moving Average (SMA5) | $4.77 |
|---|---|
| 10 Day Moving Average (SMA10) | $4.83 |
| 20 Day Moving Average (SMA20) | $5.35 |
| 50 Day Moving Average (SMA50) | $5.08 |
| 100 Day Moving Average (SMA100) | $9.47 |
| 200 Day Moving Average (SMA200) | $10.67 |
Atara Biotherapeutics, Statistics
| Average Volume (30 Days) | 391.78K |
|---|---|
| P/E Ratio (Current) | 1.29 |
| EPS (Current) | $4.00 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 0.57 |
| Current Ratio | 0.82 |
| Quick Ratio | 0.82 |
| Debt to Equity | 0.00 |
| Enterprise Value | $33.80M |
| EV to EBITDA | 0.89 |
| EV to Sales | 0.28 |
| Price to Book | -1.10 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 0.35 |
| Return on Assets | 1.62% |
| Return on Equity | -0.85% |
Atara Biotherapeutics, Stock Splits
There has been 1 stock split for Atara Biotherapeutics, (ATRA). The reverse stock split occured on June 20, 2024 and reduced the outstanding shares at a ratio of 25:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 20, 2024 | Reverse | 25:1 |
Atara Biotherapeutics, Dividends
There have been no dividends for Atara Biotherapeutics, (ATRA).